Navigation Links
In Texas, Favorable Regulations for Physicians May Backfire in Light of Market Downturn

Lower-Than-Expected Patient Volumes Seen in Houston Physician-Owned Hospitals, According to New Reports from HealthLeaders-InterStudy

NASHVILLE, Tenn., March 23 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that while Texas laws favoring physicians have traditionally enabled doctors practicing in the state to compete directly with health systems, these regulations may actually yield increasing challenges for this sector. According to the recent Houston Market Overview and San Antonio Market Overview, positives for the physician sector are tempered by economic conditions and a challenging contracting environment.

Texas has no certificate-of-need requirements for healthcare facilities and state law bars hospitals from employing physicians in most cases--two factors that have allowed doctors to build their own hospitals and facilities. There are more physician-owned hospitals in Texas than in any other state.

Meanwhile, the current economic environment finds many patients delaying care, a situation that will intensify as more consumers adopt health plans with higher copays and deductibles.

In the Houston market, home to more than a dozen acute-care facilities with physician investors, the area's physician-owned hospitals have an additional challenge: difficulty securing managed care contracts. Physician-owned University General Hospital and Foundation Surgical Hospital have contracts with one major insurer each--Aetna and UnitedHealth, respectively. Each hospital has seen lower-than-expected patient volumes.

"The Houston market has seen many hospitals open in recent years. For physician-owned facilities, today's environment, with reduced patient volumes and limited managed care contracts, makes it difficult for them to become profitable," said Mark Cherry, market analyst with HealthLeaders-InterStudy. "In areas like Houston and San Antonio we'll likely see physicians begin to work more closely with health systems, and consolidation among the overall health system segment as these players look to become more efficient."

Why Pharmaceutical Companies Need Market Overviews

Market Overviews provide a detailed analysis of local healthcare market drivers in 87 of the nation's most dynamic metro areas, allowing pharmaceutical executives to quickly gain local area expertise. Each report provides local-level insights into: health systems and hospitals, physicians, health plans, Medicare/Medicaid, pharmaceutical environment, legislation and employers.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Lisa Osgood                      Elizabeth Marshall
    HealthLeaders-InterStudy         Decision Resources, Inc.
    781-296-2606                     781-296-2563     

SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Crdentia Promotes Kevin Bollin to Area Manager of Austin, Dallas and San Antonio, Texas, Markets
2. Austin, Texas, Physicians Second in Nation to Perform New Procedure for Difficult-to-Treat Atrial Fibrillation Cases
3. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
4. Some drug studies more likely to have favorable conclusions
5. Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting
6. Pharmion and MethylGene Present Favorable Clinical Data From Combination MGCD0103/Vidaza(R) Study in Myelodysplastic Syndromes and Acute Myelogenous Leukemia at The 49th American Society of Hematology (ASH) Meeting
7. INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of Patients With Schizophrenia
8. Memry Corporation Plans to Appeal Unfavorable Court Result
9. CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
10. Senetek PLC Resolves Dispute With Marketer of Pyratine-6(TM) on Most Favorable Terms
11. Non-parental care of infants tied to unfavorable feeding practices
Post Your Comments:
(Date:11/29/2015)... ... November 29, 2015 , ... Effective immediately, every single IguanaMed scrub style ... Black Friday Target is offering a “Buy One Scrub Set, Get the 2nd Scrub ... to purchase IguanaMed at a discounted price. , IguanaMed’s mission is to ...
(Date:11/28/2015)... ... ... Safe storage for contraceptive devices may not always be easy to find. ... the other from Bradley Beach, New Jersey, there is an easy solution to the ... replace NuvaRings more often than necessary. As such, it affords peace of mind and ...
(Date:11/28/2015)... CA (PRWEB) , ... November 28, 2015 , ... Pixel ... fully customizable media panels to choose from, the possibilities are endless. Users have full ... more. With the ProPanel: Pulse masking effects, users are sure to get heads to ...
(Date:11/27/2015)... , ... November 27, 2015 , ... According to an ... by the University of Toronto and the University of British Columbia suggested that laws ... head injuries. The article explains that part of the reason for the controversial conclusion ...
(Date:11/27/2015)... ... ... A team of Swiss doctors has released a report on mesothelioma relapse ... the findings on the website. Click here to read the details now. ... who were treated with chemotherapy followed by EPP surgery. Among the 106 patients who ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)... , Nov. 29, 2015  At this year,s ... to experience the most complete mobile C-arm portfolio with ... is Ziehm Vision RFD 3D, the world,s only 3D ... edge length per scan volume. In addition, Ziehm Imaging ... motorized mobile C-arm in four axes which is ideally ...
(Date:11/29/2015)... CORALVILLE, Iowa , Nov. 29, 2015 /PRNewswire/ ... in ultrasound guidance technology at the Radiological Society ... conference in Chicago November ... guidance system is designed to offer customers unrivaled ... outcomes. --> ...
(Date:11/27/2015)... 2015 Une nouvelle approche ... Bremachlorin contre le cancer avancé.    ... l,immunothérapie au traitement photodynamique au Bremachlorin contre le ... Une nouvelle approche consistant à combiner l,immunothérapie au ...    Clinical Cancer Research . ...
Breaking Medicine Technology: